Novartis AG - Enterprise Value To Ebitda Ratio

Novartis AG's Fiscal Year is From January To December.

The item "Enterprise-Value-To-Ebitda-Ratio" stands at 11.57 as of 09/30/2025.

As of the end of Novartis AG's third quarter, the item "Enterprise Value To Ebitda Ratio" stands at 11.57. This represents an increase of 0.01 percent compared to it's value at the end of it's second quarter .


Regarding the One-Year-Change of the series, the current value constitutes a decrease of -3.26 percent compared to the value the year prior.
The 1 year change in percent is -3.26.
The 3 year change in percent is 166.09.

The Serie's long term average value is 9.67. It's latest available value, on 09/30/2025, is 19.63 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 09/30/2022, to it's latest available value, on 09/30/2025, is +166.09%.
The Serie's change in percent from it's maximum value, on 09/30/2024, to it's latest available value, on 09/30/2025, is -3.26%.